Clinical trials: Enterococcal Endocarditis
Endocarditis, Bacterial
Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.
The aim of this study is to determine the safety and efficacy of daptomycin when used as an adjuvant agent to standard care in the treatment of proven native valve Enterococcal endocarditis.
- Trial name
- NCT00401960
- Testing
- Daptomycin
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- Weill Medical College of Cornell University